Relapsed and Refractory Disease and Emerging Therapies 

Listen as the experts discuss the emerging therapies for AML.
Faculty:
Aref Al-Kali, MD
Assistant Professor of Medicine
Leukemia Advanced Fellowship, Program Director
Division of Hematology
Mayo Clinic
Rochester, Minnesota
And
Martin S. Tallman, MD
Chief, Leukemia Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, New York